(Q34907163)

5 August 2017

title

Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases (English)

1 reference

5 August 2017

R A Brodsky

1

1 reference

5 August 2017

L Luznik

2

1 reference

5 August 2017

J Bolaños-Meade

3

1 reference

5 August 2017

M S Leffell

4

1 reference

5 August 2017

R J Jones

5

1 reference

5 August 2017

E J Fuchs

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

14 July 2008

1 reference

Bone Marrow Transplantation

5 August 2017

published in

1 reference

5 August 2017

volume

42

1 reference

5 August 2017

issue

8

1 reference

5 August 2017

page(s)

523-527

1 reference

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Bone marrow engraftment analysis after allogeneic bone marrow transplantation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Cyclophosphamide-induced immunological tolerance: an overview

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Clues to the pathogenesis of familial colorectal cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Assessment of aldehyde dehydrogenase in viable cells.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBMT.2008.203

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Availability of related donors for bone marrow transplantation in sickle cell anemia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086163

Elimination of alloantibodies by immunoablative high-dose cyclophosphamide

9 December 2018

1 reference

12 December 2020

Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia

1 reference

12 December 2020

Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A

1 reference

12 December 2020

Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation

1 reference

12 December 2020

The use of amplified variable number of tandem repeats (VNTR) in the detection of chimerism following bone marrow transplantation. A comparison with restriction fragment length polymorphism (RFLP) by Southern blotting

1 reference

12 December 2020

Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease

1 reference

12 December 2020

Cord blood transplantation for sickle cell anemia: bust or boom?

1 reference

12 December 2020

Interphase FISH for Y chromosome, VNTR polymorphisms, and RT-PCR for BCR-ABL in the monitoring of HLA-matched and mismatched transplants

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2008.203

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference